Category Archives: ALS Treatment

Dr. Disneys research confronts diseases that include Alzheimers, ALS, muscular dystrophy and, recently, the coronavirus. JUPITER A scientist at Scripps Research Institute studying brain diseases and the novel coronavirus has received a hefty grant from the National Institute of Neurological Disorders and Stroke. Continue reading →

A year ago, Chad McBride was the chair of the communications studies department at Creighton University in Omaha, Nebraska. He and his husband, Allen Saunders, were raising their 3-year-old son, Jackson, in a close-knit community of friends, neighbours, and colleagues. [Life] was beyond magical, McBride, 44, told Insider. Continue reading →

An outbreak of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection has posed significant threats to international health and the economy. In the absence of specific treatment for this virus, there is an urgent need to learn from the experience and lessons in China. To reduce the case-fatality rate among COVID-19 patients, we should not ignore the complications, such as RNAaemia, acute respiratory distress syndrome, and multiple organ dysfunction. Continue reading →

Clinical trials produce a massive amount of medically relevant and highly sensitive data. Leveraging such data could make a difference to efforts to create more personalized, effective medicines Continue reading →

GREENVILLE, N.C., March 25, 2020 /PRNewswire/ --Robert C. Continue reading →

"What BL-001 attempts to do is to modify the microorganisms in the stomach to restore the GABA and glutamate levels that are disrupted in the brains of people living with ALS," said Kuldip Dave, Ph.D., vice president of research at The ALS Association. "It's a fascinating approach to using the body's own protective bacteria to reset dysfunctional neurotransmitters that lead to loss of motor control." "We are witnessing incredible innovation in the field of microbiota-based therapeutics and research," said Bloom's CEO Christopher Reyes, PhD Continue reading →

Elon Musk has opened up about contracting malaria in 2000, saying he had a "near fatal case" of the disease. In several tweets on Monday night, the Tesla and SpaceX CEO described what happened when he contracted falciparum, a potentially fatal form of malaria that can affect the central nervous system or cause "acute respiratory distress," according to the Centers for Disease Control and Prevention. Continue reading →

LA JOLLA, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the Company), an immunology company developing treatments that harness the patients innate immune system to fight disease, today reported its financial results for the fourth quarter and full year ended December 31, 2019 and is providing a business update Continue reading →

Read Time: Delivering the medication dantrolene through the nose rather than the mouth may help the medication penetrate the brain more effectively, potentially maximizing its therapeutic benefits in the treatment of neurodegenerative diseases, like Alzheimer's disease. In a first-of-its-kind study, researchers in the Perelman School of Medicine (PSOM) at the University of Pennsylvania showed that administering dantrolene through the nose increased its brain concentration and duration in a mouse model of Alzheimer's disease without causing obvious adverse side effects. Continue reading →

VIKEN, Sweden - March 13, 2020 - (Newswire.com) TIKOMED, a Swedish privately-held biopharmaceutical company today announced that it has successfully completed a 5 million Euro round of financing from current investors. The capital will primarily be used to support the ongoing clinical development program for ILB and IBSOLVMIR, advancing the companys position within the treatment of acute and degenerative neurological diseases and cell transplantation Continue reading →